Cargando…
Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
Autores principales: | Golubnitschaja, Olga, Yeghiazaryan, Kristina, Schild, Hans H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125929/ http://dx.doi.org/10.1186/1878-5085-5-S1-A77 |
Ejemplares similares
-
Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?
por: Golubnitschaja, Olga, et al.
Publicado: (2012) -
“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
por: Golubnitschaja, Olga, et al.
Publicado: (2014) -
Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014) -
Innovative strategies for prediction and targeted prevention of glaucoma in healthy vasospastic individuals: context of neurodegenerative pathologies
por: Yeghiazaryan, Kristina, et al.
Publicado: (2014) -
Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments
por: Yeghiazaryan, Kristina, et al.
Publicado: (2011)